Effect of a Mushroom Extract-Containing Topical Cosmetic Formulation During Breast Radiotherapy
NCT07755553
Breast Cancer, Breast Diseases
Sant Joan d'Alacant, Alicante, Spain
View Trial DetailsNCT Number: NCT00188721
This study aims to evaluate if a light based technique, called Transillumination Breast Spectroscopy (TIBS), can be used to construct a non-invasive breast cancer risk predictor which provides a better odds ratio than mammographic parenchymal density.
Looking for future studies?
Notify Me30 year–70 year
Female
Observational
Ontario Cancer Institute, Princess Maraget Hospital, Toronto, Ontario, Canada
In a previous cross sectional study in a group of women without breast cancer and with varying degrees of parenchymal density patterns, a strong association was demonstrated between Transillumination Breast Spectroscopy (TIBS) and x-ray derived mammographic density. From this, we expect that TIBS should also provide a comparable odds ratio (4-6) as mammographic density for breast cancer risk shown in other independent epidemiological studies. It is possible that TIBS may provide complementary information and a higher odds ratio if compared to the incidence of breast cancer. In contrast to mammography derived parenchymal density pattern, no historical TIBS data is available for a retrospective analysis and hence a cross sectional study within a group of screened women is proposed. We hypothesize that TIBS provides physical information about the breast tissue which can be used to construct a breast cancer risk predictor with an odd ratio > 6.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University Health Network, Toronto
Other
Transillumination for Breast Cancer Risk Assessment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07755553
Breast Cancer, Breast Diseases
Sant Joan d'Alacant, Alicante, Spain
View Trial DetailsNCT00043472
Adnexal Diseases, Breast Cancer
Bethesda, Maryland, United States
View Trial DetailsNCT00469339
Breast Cancer, Breast Diseases
Houston, Texas, United States
View Trial DetailsNCT00006421
Breast Cancer, Breast Diseases
Bethesda, Maryland, United States
View Trial Details